EUVIMEDScopri EUVIMED
Randomisierte kontrollierte StudieVergleichsstudieOpen access · CC BY-NC 4.0

Biosensor Compared With Standard Care to Identify Extravasation Injuries in Paediatric Intensive Care: A Randomised Controlled Trial

Craig A McBride iD, Sarfaraz Rahiman iD, Melanie Kennedy, Luregn J Schlapbach iD, Jessica A Schults iD, Tricia M Kleidon iD, Thim Baveas, Rebecca Paterson iD, Joshua Byrnes iD, Robert S Ware iD, Amanda J Ullman iD

Journal of Paediatrics and Child Health · 2026-06 · 62 (6) · 1034-1043

DOI: 10.1111/jpc.70378 ↗

At a glance

Randomisierte kontrollierte Studie in Journal of Paediatrics and Child Health, published online on 2026-04-14. Written by Craig A McBride and 10 co-authors. Institution: Surgical Team: Infants, Toddlers, Children (STITCh), Queensland Children's Hospital, South Brisbane, Queensland, Australia. Major MEDLINE topics: Extravasation of Diagnostic and Therapeutic Materials, Biosensing Techniques, Catheterization, Peripheral. Cited 1 times so far (Crossref); 40 references. The full text is freely available (open access, CC BY-NC 4.0). Funded by: Children's Hospital Foundation, ivWatch LLC.

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

Aim

To evaluate whether, in children treated in paediatric intensive care units (PICU) with peripheral venous access devices (PVADs) receiving intermediate‐ or high‐risk peripheral intravenous medications, the use of a tissue‐infiltration biosensor (ivWatch), compared to standard care, reduces extravasation injuries.

Methods

A superiority, parallel group randomised controlled trial conducted in a single Queensland quaternary hospital PICU from September 2020 to July 2022. Children with PVADs inserted in the distal half of the limb and receiving intermediate‐ to high‐risk infusates for ≥ 24 h were randomly allocated in a 1:1 ratio to biosensor (ivWatch monitor applied within 10–15 mm of the PVAD tip) plus standard clinical observation, or standard observation alone. Primary outcome was extravasation severity on the 4‐point Cincinnati Children's Hospital Medical Centre Extravasation Harm Scale. Injuries were compared between treatment groups using ordinal logistic regression.

Results

A total of 175 children were enrolled, 88 to biosensor and 87 to standard care. Extravasation severity was similar between groups, with no, mild and moderate injury occurring in 56 (69%), 25 (30%) and 2 (2%) participants in the biosensor group and 61 (70%), 24 (28%) and 2 (2%) in the standard care group (proportional odds ratio = 1.13; 95% CI: 0.59, 2.15, p = 0.71). No statistically significant between‐group differences in extravasation severity, volume, treatment sequelae, PVADs used or dwell time were observed. The biosensor was acceptable to nurses.

Conclusions

In this PICU population, biosensor monitoring in addition to standard care did not significantly reduce extravasation injuries. The technology was acceptable to bedside nursing staff. Trial Registration: ACTRN12620000317998

Subjects

MeSH terms (MEDLINE)

Extravasation of Diagnostic and Therapeutic MaterialsBiosensing TechniquesCatheterization, PeripheralHumansIntensive Care Units, PediatricQueenslandFemaleMaleChild, PreschoolInfantChildInfusions, Intravenous

Author keywords

extravasationivWatchpaediatric intensive carevesicant medication

Authors and institutions

  • Surgical Team: Infants, Toddlers, Children (STITCh), Queensland Children's Hospital, South Brisbane, Queensland, Australia.
  • NHMRC Centre for Wiser Wound Care, Griffith University, Nathan, Queensland, Australia.
  • Pegg Leditschke Children's Burns Centre, Children's Health Queensland, South Brisbane, Queensland, Australia.
  • Child Health Research Centre, the University of Queensland, South Brisbane, Queensland, Australia.
  • Paediatric Intensive Care Unit, Queensland Children's Hospital, South Brisbane, Queensland, Australia.
  • Department of Intensive Care Medicine and Neonatology, Children's Research Center, University Children's Hospital Zürich, University of Zurich, Zurich, Switzerland.

ORCID profiles: Craig A McBride, Sarfaraz Rahiman, Luregn J Schlapbach, Jessica A Schults, Tricia M Kleidon, Rebecca Paterson, Joshua Byrnes, Robert S Ware, Amanda J Ullman

Funding

  • Children's Hospital Foundation
  • ivWatch LLC

Cite

APA

McBride, C. A., Rahiman, S., Kennedy, M., Schlapbach, L. J., Schults, J. A., Kleidon, T. M., Baveas, T., Paterson, R., Byrnes, J., Ware, R. S., & Ullman, A. J. (2026). Biosensor Compared With Standard Care to Identify Extravasation Injuries in Paediatric Intensive Care: A Randomised Controlled Trial. Journal of Paediatrics and Child Health, 62(6), 1034-1043. https://doi.org/10.1111/jpc.70378

Vancouver

McBride CA, Rahiman S, Kennedy M, Schlapbach LJ, Schults JA, Kleidon TM, et al. Biosensor Compared With Standard Care to Identify Extravasation Injuries in Paediatric Intensive Care: A Randomised Controlled Trial. Journal of Paediatrics and Child Health. 2026;62(6):1034-1043. doi:10.1111/jpc.70378

BibTeX
@article{McBride2026,
  author = {McBride, Craig A and Rahiman, Sarfaraz and Kennedy, Melanie and Schlapbach, Luregn J and Schults, Jessica A and Kleidon, Tricia M and Baveas, Thim and Paterson, Rebecca and Byrnes, Joshua and Ware, Robert S and Ullman, Amanda J},
  title = {Biosensor Compared With Standard Care to Identify Extravasation Injuries in Paediatric Intensive Care: A Randomised Controlled Trial},
  journal = {Journal of Paediatrics and Child Health},
  year = {2026},
  volume = {62},
  number = {6},
  pages = {1034--1043},
  doi = {10.1111/jpc.70378}
}
Start for free →